John Bloom
Angel Investor
Indianapolis, United States
John Bloom is a Series A investor in Indianapolis focused on Medical and Software. John Bloom John C. Bloom holds a B.S. degree in biology from the University of Pittsburgh and doctorates in veterinary medicine and experimental hematology from the University of Pennsylvania. He completed his postdoctoral training at the Jefferson Medical College in hematology/oncology and served on the Faculty of the University off Pennsylvania School of Veterinary Medicine as Chief, Clinical Laboratory Medicine, before joining Smith Kline & French Laboratories as Associate Director of Pathology. Dr. Bloom has been active in the fields of toxicology, clinical risk assessment and translational biomarker research within the pharmaceutical industry, FDA and Institute of Medicine and has authored several manuscripts, chapters, reviews and texts on these topics. He served as Head, Clinical Pathology, in the Toxicology Division of Lilly Research Laboratories, where he subsequently moved to the Medical Division to establish the departments of Experimental Medicine and Clinical Diagnostic Services, which were responsible for translational biomarker research; and laboratory, ECG, imaging and specimen banking support for global clinical development, respectively. Upon his retirement from Lilly in 2009 he established Bloom Consulting Services, LLC, which he serves as President, and was appointed Consultant, Office of the Center Director, FDA. Dr. Bloom holds adjunct academic appointments at the University of Pennsylvania and Purdue University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries John Bloom invests in
Stages John Bloom invests in
Countries John Bloom invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Software 1 (50%)
- Health Care 1 (50%)
- Service Industry 1 (50%)
Stage
- Series A 1 (50%)
- Funding Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| At Doctrin, they are passionate about improving healthcare. They strive to make patients healthier and happier, and healthcare professionals more effective at work. They achieve this by providing digital tools automating and simplifying as much of the patient journey as possible, for as many patients as possible. | $9.6M / Series A / Dec 11, 2017 | ||
| See all 2 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does John Bloom invest in?
John Bloom invests primarily in Medical, Software and Health Care startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact John Bloom?
Public channels for John Bloom include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did John Bloom last invest?
The most recent investment recorded for John Bloom closed in Dec 2017. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
